Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Werner

Showing results (51-60 of 99) with videos related to

Pageof 10
Sort By:
Gynecologic Oncology|December 15, 2020
Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancerD Forsse, H F Berg, O Bozickovic, et al.
Frontiers in Oncology|June 14, 2023
The impact of adipose tissue distribution on endometrial cancer: a systematic reviewAnouk A S van den Bosch, Johanna M A Pijnenborg, Andrea Romano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2015
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomasSigmund Ytre-Hauge, Jenny A Husby, Inger J Magnussen, et al.
Oncotarget|July 8, 2016
Androgen receptor as potential therapeutic target in metastatic endometrial cancerIngvild Løberg Tangen, Therese Bredholt Onyango, Reidun Kopperud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2012
A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosisH M J Werner, J Trovik, J Marcickiewicz, et al.
British Journal of Cancer|November 2, 2013
Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomasI S Haldorsen, I Stefansson, R Grüner, et al.
Gynecologic Oncology|November 4, 2017
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesionsTina Fonnes, Hege F Berg, Therese Bredholt, et al.
Plos One|May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progressionIngvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Cancer|October 30, 2013
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancerHelen J Mackay, Elizabeth A Eisenhauer, Suzanne Kamel-Reid, et al.
Pageof 10

Showing results (51-60 of 99) with videos related to

Sort By:
Pageof 10
Gynecologic Oncology|December 15, 2020
Maintained survival outcome after reducing lymphadenectomy rates and optimizing adjuvant treatment in endometrial cancerD Forsse, H F Berg, O Bozickovic, et al.
Frontiers in Oncology|June 14, 2023
The impact of adipose tissue distribution on endometrial cancer: a systematic reviewAnouk A S van den Bosch, Johanna M A Pijnenborg, Andrea Romano, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2015
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomasSigmund Ytre-Hauge, Jenny A Husby, Inger J Magnussen, et al.
Oncotarget|July 8, 2016
Androgen receptor as potential therapeutic target in metastatic endometrial cancerIngvild Løberg Tangen, Therese Bredholt Onyango, Reidun Kopperud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 20, 2012
ARID1A loss is prevalent in endometrial hyperplasia with atypia and low-grade endometrioid carcinomasHenrica M J Werner, Anna Berg, Elisabeth Wik, et al.
European Journal of Cancer (Oxford, England : 1990)|October 6, 2012
A discordant histological risk classification in preoperative and operative biopsy in endometrial cancer is reflected in metastatic risk and prognosisH M J Werner, J Trovik, J Marcickiewicz, et al.
British Journal of Cancer|November 2, 2013
Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomasI S Haldorsen, I Stefansson, R Grüner, et al.
Gynecologic Oncology|November 4, 2017
Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesionsTina Fonnes, Hege F Berg, Therese Bredholt, et al.
Plos One|May 23, 2014
Switch in FOXA1 status associates with endometrial cancer progressionIngvild Løberg Tangen, Camilla Krakstad, Mari K Halle, et al.
Cancer|October 30, 2013
Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancerHelen J Mackay, Elizabeth A Eisenhauer, Suzanne Kamel-Reid, et al.
Pageof 10